Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tetra Bio Pharma Inc (TBP.VN)

Tetra Bio Pharma Inc (TBP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 60,594
  • Shares Outstanding, K 281,833
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.31
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.51
Trade TBP.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.185 +16.22%
on 07/29/20
0.255 -15.69%
on 07/16/20
+0.005 (+2.38%)
since 06/30/20
3-Month
0.185 +16.22%
on 07/29/20
0.350 -38.57%
on 05/08/20
-0.125 (-36.76%)
since 04/30/20
52-Week
0.170 +26.47%
on 10/21/19
0.690 -68.84%
on 01/17/20
-0.060 (-21.82%)
since 07/30/19

Most Recent Stories

More News
Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003

Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product A new anti-inflammatory drug candidate OTTAWA, ON / ACCESSWIRE / August 18, 2020 / Tetra Bio-Pharma...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
TBP.VN : 0.215 (+2.38%)
Tetra Bio-Pharma and Mondias Enter Into Final Agreement For The Purchase Of Lumiera Health Innovation Inc.

MONTREAL, QC / ACCESSWIRE / August 17, 2020 / Mondias Natural Products Inc. (TSXV:NHP) (the "Company" or "Mondias") specializing in evidence-based natural products for the healthcare and bio-agriculture...

TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)
CORRECTION FROM SOURCE: Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Please disregard original release sent out and replace with the following. Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise...

TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)
Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise OTTAWA, ON / ACCESSWIRE / August 6, 2020 / Tetra Bio-Pharma Inc. ("Tetra"...

TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)
49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3rd - 6th, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting...

CG1.AX : 0.061 (-15.28%)
ISDR : 11.59 (-0.52%)
KNM.AX : 0.002 (unch)
PLL.AX : 0.215 (unch)
SKF.AX : 0.031 (-11.43%)
TGM.AX : 0.155 (-3.13%)
QFE.AX : 0.082 (-11.83%)
VTI.AX : 0.165 (unch)
VHT.AX : 1.140 (unch)
AIM : 0.4757 (-3.92%)
WTER : 0.0016 (-84.00%)
WTER.CN : 0.1950 (-11.36%)
Tetra Bio-Pharma’s Management Provides Corporate Update on QIXLEEF(TM) & CAUMZ(TM) Drug Development Activities

- Resumption of its PLENITUDE© clinical trial on-time; - CAUMZ™ manufacturing set to begin in USA to allow start of clinical trials; - QIXLEEF™ metabolite mapping study to be complete in Q3 2020...

FDC : 31.69 (+8.71%)
TBP.VN : 0.215 (+2.38%)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Provides Management Update on Pharma Focus

OTTAWA, CANADA / ACCESSWIRE / July 27, 2020 /Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is providing its...

TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)
FDA Provides Positive Feedback on Tetra Bio-Pharma's Pre-Investigational New Drug Application for ARDS-003 to Be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome (ARDS)

FDA stated that the nonclinical program was appropriate to support initiating studies in COVID-19 patients

TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)
Tetra Bio-Pharma Receives Conditional Approval to Graduate to the TSX

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TBP.VN : 0.215 (+2.38%)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Appoints Steve Edgett As A Strategic Advisor

OTTAWA / ACCESSWIRE / July 9, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce...

HON : 190.36 (-0.19%)
TBPMF : 0.0002 (-77.78%)
TBP.VN : 0.215 (+2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.222
1st Resistance Point 0.218
Last Price 0.215
1st Support Level 0.208
2nd Support Level 0.202
3rd Support Level N/A

See More

52-Week High 0.690
Fibonacci 61.8% 0.491
Fibonacci 50% 0.430
Fibonacci 38.2% 0.369
Last Price 0.215
52-Week Low 0.170

See More

Business Summary

Tetra Bio Pharma Inc is a multi-subsidiary publicly traded company engaged in the development of biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements. The company is engaged in pain management research including medical cannabis, consultations, and...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar